Lv5
1590 积分 2023-12-04 加入
Transarterial Chemoembolization in Combination with a Molecular Targeted Agent: Lessons Learned from Negative Trials (Post-TACE, BRISK-TA, SPACE, ORIENTAL, and TACE-2)
2天前
已完结
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
3天前
已完结
MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma
3天前
求助中
MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma
4天前
已关闭
“TACE抵抗/失败”—需要全面认识
13天前
已完结
中国肝细胞癌经动脉化疗栓塞（TACE）治疗临床实践指南（2023年版）
13天前
已完结
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
15天前
已完结
Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma
1个月前
已完结
前瞻性临床研究中基于免疫检查点抑制剂治疗不可切除肝细胞癌的不良反应:系统综述和Meta分析
2个月前
已完结
皖公网安备34019202002308
